116 related articles for article (PubMed ID: 20957442)
1. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.
Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Ann Surg Oncol; 2011 Mar; 18(3):880-7. PubMed ID: 20957442
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma.
Yang X; Xiong G; Chen X; Xu X; Wang K; Fu Y; Yang K; Bai Y
J Cancer Res Clin Oncol; 2009 Oct; 135(10):1341-9. PubMed ID: 19352701
[TBL] [Abstract][Full Text] [Related]
3. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
Bayram S; Akkız H; Bekar A; Akgöllü E
Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
[TBL] [Abstract][Full Text] [Related]
4. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
5. p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.
Yang W; Qi Q; Zhang H; Xu W; Chen Z; Wang L; Wang Y; Dong X; Jiao H; Huo Z
Ann Surg Oncol; 2010 May; 17(5):1453-8. PubMed ID: 20112071
[TBL] [Abstract][Full Text] [Related]
6. CASP8 -652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/prognosis of ESCC: a case control study in northern Indian population.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
J Surg Oncol; 2011 Jun; 103(7):716-23. PubMed ID: 21308686
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 -330T>G genetic polymorphism associates with prognosis following surgery for thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Yoshino K; Nakatsu T; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2011 Jul; 18(7):1995-2002. PubMed ID: 21258967
[TBL] [Abstract][Full Text] [Related]
8. Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: a case-control study and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
J Gastroenterol Hepatol; 2013 Nov; 28(11):1717-24. PubMed ID: 23869757
[TBL] [Abstract][Full Text] [Related]
9. Survivin promoter polymorphism and cervical carcinogenesis.
Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
[TBL] [Abstract][Full Text] [Related]
10. Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India.
Ihsan R; Chattopadhyay I; Phukan R; Mishra AK; Purkayastha J; Sharma J; Zomawia E; Verma Y; Mahanta J; Saxena S; Kapur S
J Gastroenterol Hepatol; 2010 Aug; 25(8):1456-62. PubMed ID: 20659238
[TBL] [Abstract][Full Text] [Related]
11. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer.
Shibuta J; Eto T; Kataoka A; Inoue H; Ueo H; Suzuki T; Barnard GF; Mori M
Am J Gastroenterol; 2001 Dec; 96(12):3419-24. PubMed ID: 11774959
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of c-myc gene in esophageal squamous cell carcinoma].
He J; Zhang RG; Zhu D
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):94-6, 127. PubMed ID: 7767777
[TBL] [Abstract][Full Text] [Related]
15. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma].
Dong ZM; Cui YJ; Kuang G; Wang R; Yu FL; Zhang JH
Ai Zheng; 2005 Oct; 24(10):1225-9. PubMed ID: 16219137
[TBL] [Abstract][Full Text] [Related]
17. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
[TBL] [Abstract][Full Text] [Related]
18. Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Clin Immunol; 2008 Aug; 128(2):199-204. PubMed ID: 18502691
[TBL] [Abstract][Full Text] [Related]
19. [Association of single nucleotide polymorphism of MnSOD gene with carcinogenesis and development of esophageal squamous cell carcinoma].
Cheng YJ; Wang YD; Liu Q; Dong ZM; Wu FP; Yang XR; Qiao XY; Zhang J
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):831-5. PubMed ID: 20137347
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
